1. Introduction
===============

Upper respiratory tract infections (URIs) can be a serious burden to the healthcare system.^\[[@R1]\]^ The majority of URIs are of viral etiology, but definitive diagnosis can be difficult due to the overlapping clinical presentations of viral and bacterial infections, and the variable sensitivity, and lengthy turn-around time of viral culture.^\[[@R1]\]^ The rapid and sensitive detection of respiratory viruses is essential for the early diagnosis and administration of appropriate antiviral therapy, as well as for the effective implementation of infection control measures.^\[[@R2]\]^

The FilmArray Respiratory Panel (FA-RP) assay is a fully automated, multiplex PCR system, which integrates nucleic acid extraction, nested amplification and detection in a reaction pouch preloaded with all reagents required for detection of 17 viruses and 3 bacteria.^\[[@R3]\]^ It does not require advanced equipment or expertise in molecular diagnostics, making it a useful point-of-care test for acute respiratory infections,^\[[@R3]\]^ and a valuable tool for the assessment of the age-related prevalence of the responsible pathogens.

2. Methods
==========

In order to investigate the age-related prevalence of each respiratory pathogen, we retrospectively studied the results of all the samples, which had been processed during 1 year-period (November 2015 to November 2016) with the FA-RP, in the Central Laboratories of Hygeia & Mitera General Hospitals of Athens, Greece. Among 656 respiratory samples (Rs) tested, 362 (55%) were from male and 294 (45%) from female patients, while the median age of these 656 patients was 7 years old (0.1--92). In order to have an age-related distribution, the following age groups were implemented: (\<2), (≥2, \<5), (≥5, \<10), (≥10, \<18), (≥18, \<45), (≥45, \<65) and (≥65) years old. Ethical approval and/or patient consent were not necessary, because the paper does not report on primary research and all data analyzed were retrospectively collected as part of routine diagnosis.

2.1. BioFire FA-RP
------------------

Nasopharyngeal swab specimens were collected from patients with symptomatic respiratory tract infection and processed with FA-RP.^\[[@R4]\]^ The assay detects nucleic acids of 17 respiratory viruses and 3 bacteria, including adenovirus (Adv), coronaviruses (HCoV: OC43, NL63, 229E and HKU1), human respiratory syncytial virus (HRSV or RSV), human metapneumovirus (Hmpv), influenza A virus (H1/2009, H1 and H3), influenza B virus, parainfluenza viruses (PIV, including PIV-1 to PIV-4), human rhinovirus/enterovirus (HRV), *Bordetella pertussis*, *Chlamydophila pneumoniae*, and *Mycoplasma pneumoniae* in a multiplex PCR.^\[[@R4]\]^ The extraction, amplification, and detection steps take place in separate chambers of a self-contained, single-use pouch. The procedures were performed according to the manufacturer\'s instructions.

2.2. Statistical analysis
-------------------------

Chi-square tests and SPSS Statistics 17.0 (SPSS, Chicago, IL, USA) were used for statistical analysis, while *P* \< .05 was considered statistically significant.

3. Results
==========

3.1. Spectrum of respiratory pathogens detected
-----------------------------------------------

Among 656 respiratory samples tested, 356/656 (54.3%) were positive and 300/656 (45.7%) were negative. The total number of pathogens detected was larger than the positive samples, due to the frequent multiple isolations. Thus, 420 pathogens were detected, with HRV, Adv and influenza viruses (A and B) being the most usual isolated pathogens (Table [1](#T1){ref-type="table"}).
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The spectrum of pathogens detected by the FA-RP, irrespective of single or multiple identifications.
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3.2. Age-related distribution of respiratory pathogens
------------------------------------------------------

In the first age-group (\<2), 41 out of 121 samples (33.9%) revealed HRV, 16/121 (13.2%) Adv, 10/121 (8.3%) RSV, 10/121 (8.3%) coronavirus (229Ε, NL63, OC43, and ΗΚU1), 9 (7.4%) Hmpv, and 9 (7.4%) PIV (1, 2, and 3). In the age-group (≥2, \<5), Adv predominated with 37 out of 147 samples (25.2%), followed by HRV (29/147, 19.7%), RSV (16/147, 16.9%), coronavirus (all types), and influenza (A and B), (14/147, 9.5%) each, Hmpv (12/147, 8.2%) and PIV (1, 2, and 3), 9 (6.1%). In the age-group (≥5, \<10), HRV was identified in 25/80 samples (31.3%), Adv in 18/80 (22.5%), influenza (A and B) in 11 (13.8%), and Hmpv in 6/80 (7.5%). Influenza predominated in the age-group (≥10, \<18), with 4/22 samples (18.2%), while in the remaining 3 age-groups (≥18), HRV was the commonest isolated pathogen 33/286 (11.5%), followed by Influenza with 20/286 (7%) (influenza A H1-2009, 11/20). The frequency of each pathogen in each respective age-group has been displayed in Figure [1](#F1){ref-type="fig"}. There was a statistically significant difference between all age groups, for HRV (*P* \< .001), Adv (*P* \< .001), influenza (ALL) (*P* = .02), RSV (*P* = .002), PIV-3 (*P* = .04), and coronavirus (ALL) (*P* = .02). Based on Figure [1](#F1){ref-type="fig"}, it is obvious that HRV prevailed in all age groups, but especially in the groups (\<2) and (≥5, \<10). Among Adv positive samples, there was a significant difference between the age group (≥2, \<5) (most cases, 37/83 or 44.6%) and (≥45, \<65) (no case) (*P* = .001), while most of the RSV positive samples (26/36, 72.2%) were noticed in ages under 5 years old. In regard with samples positive for influenza (A or B), the predominance of influenza in the age group (≥10, \<18) was due to influenza B cases, while the majority of cases with influenza A H1-2009 were noticed in the ages under 10 years old (16/27, 59.3%). The latter was also true for Hmpv (27/39, 69.2%), while PIV-3, the main PIV type detected (Table [1](#T1){ref-type="table"}) had a peak incidence in ages under 5 years old (15/19, 78.9%). Finally, most cases of coronavirus (all types included) were detected in children \<10 years old (28 out of 35 cases, 80%), 10 of which (28.6%) were in children (\<2), with 2 types of coronavirus being detected in a single sample.
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3.3. Multiple detections
------------------------

Among the total Rs, 57/656 (8.7%) revealed multiple isolations. Based on positive samples only, we had multiple pathogens in 57 out of 356 positive Rs. HRV participated in most multiple isolations, being the most frequent isolated pathogen (37/57, 64.9%) (Fig. [2](#F2){ref-type="fig"}). The second more frequently observed pathogens were PIV (1, 2, and 3), identified in 24 out of 57 samples (42.1%), and Adv identified in 23 out of 57 samples (40.4%), followed by RSV (15/57, 26.3%) (Fig. [2](#F2){ref-type="fig"}). It is remarkable that the combination HRV/Adv was the most commonly observed, with 10 cases out of 57 (17.5%), followed by HRV/RSV combination (6/57, 10.5%) (Table [2](#T2){ref-type="table"}). Regarding the age-related distribution of multiple respiratory pathogens, it should be noted that most of them (41/57, 71.9%) concerned ages under 5 years old, while the combination HRV/Adv was mainly observed in the age group 2 to 10 (Table [2](#T2){ref-type="table"}).
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The age-related frequency of each respiratory combination pattern.
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3.4. Negative samples
---------------------

It was also remarkable that negative samples were mostly encountered in older ages. In particular, in the age group (\<2), 33 out of 121 patients (27.3%) revealed no pathogen and the same was true for 42/147 (28.6%) patients in the age group (≥2, \<5), 21/80 (26.3%) in the age group (≥5, \<10), 12/22 (54.5%) in the age group (≥10, \<18), 89/135 (65.9%) in the age group (≥18, \<45), 56/78 (71.8%) in the age group (≥45, \<65) and 47/73 (64.4%) in the age group ≥65 (Fig. [3](#F3){ref-type="fig"}).

![Negative samples were mostly encountered to older ages, with a peak incidence in the age group (≥45, \<65).](medi-97-e10903-g005){#F3}

4. Discussion
=============

Respiratory infections are a common cause of pediatric morbidity^\[[@R5]\]^ and the vast majority of acute URIs are caused by viruses.^\[[@R6]\]^ Molecular point-of-care testing for respiratory viruses has the potential to improve the detection rate of respiratory viruses, improve the use of influenza antivirals and reduce unnecessary antibiotic use.^\[[@R7]\]^ However, the age-related prevalence of these identifiable upper respiratory pathogens has not been clearly established. In this study, the routine clinical application of the FA-RP was indirectly used as a molecular point-of-care testing for the age-stratification of the respiratory viruses detected, in a tertiary hospital of Greece.

HRV was the most commonly identified virus in almost all age groups, but especially in the groups (\<2) and (≥5, \<10). The increasing availability of multiplex PCR panels allows rapid detection of HRV and provides the opportunity for timely treatment and early recognition of outbreaks.^\[[@R8]\]^ The predominance of HRV in our patient series is in accordance with previously published data.^\[[@R9]--[@R13]\]^ including data with patients under the age of 2.^\[[@R14]\]^ HRV has been previously identified as the most common pathogen detected among symptomatic young children in a pediatric emergency department, with the majority of them requiring hospitalization.^\[[@R15]\]^ The same was true in our series, where all cases were symptomatic and most cases had been hospitalized. Based on our results, HRV should certainly be included in the differential diagnosis of URIs in older patients, too.

In the case of Adv, our results indicate that the age group (≥2, \<5) seem to be at the highest risk of getting infected. Until now, Adv has been considered as 1 of the 5 most frequent respiratory pathogens among children,^\[[@R16]--[@R18]\]^ with infants being the population of the highest risk. In our study, Adv is referred for the first time as the most frequent responsible pathogen in the age group (≥2, \<5) and second in priority among all the identified pathogens. These results may reflect a trend of increasing total incidence and higher-age peak incidence for Adv positive cases.

RSV is a regular winter visitor that is highly contagious among persons of all ages.^\[[@R19]\]^ Although long recognized as the major viral pathogen of the lower respiratory tract of infants, it has also been implicated in severe lung disease in adults, especially the elderly.^\[[@R20],[@R21]\]^ This was not confirmed in our study, where most RSV positive samples were noticed in ages under 5 years old. However, it should be noticed that 4 out of the 5 positive cases which occurred in the ages ≥18 (data not shown), belonged to the age group (≥65), highlighting the relevance of this virus in all ages.^\[[@R22]\]^

As for samples positive for Influenza (A or B), we should underline the total prevalence of influenza A H1-2009, the high incidence of influenza A H1-2009 in ages under 10 years old and the preference of influenza B incidence in the middle ages. Influenza A and B are important causes of respiratory illness in all age groups.^\[[@R23]\]^ Influenza has been referred as the most common etiologic agent (55.7%), especially among adults.^\[[@R24]\]^ This was not true in our case, except for the age group (≥10, \<18). However, influenza A has been previously considered as 1 of the 3 most frequent pathogens in the community setting.^\[[@R16],[@R18]\]^ Our data indicate that this applies totally to ages over 5 years.

Moreover, it has been proposed that the highest incidence of Hmpv infection is among children, as seropositivity for hMPV approaches 100% by 5 to 10 years of age.^\[[@R25]\]^ In our series, although 70% of Hmpv positive cases were identified in ages under 10, we also had 12 cases after the age of 18 years old, underlying that a considerable number of Hmpv infections are diagnosed in adults and the elderly.^\[[@R25]\]^

Finally, PIV are single-stranded RNA viruses belonging to the paramyxovirus family that may cause of URIs and lower respiratory infections in infants, children and immunocompromised individuals.^\[[@R26],[@R27]\]^ It is considered that almost 90% of PIV-positive samples are from pediatric patients younger than 5 years old, with no infant under 1 month of age found positive.^\[[@R26]\]^ These were true in our series, with PIV-3 being the most representative type. Also, HCoV are considered important respiratory pathogens, especially in hospitalized children under 2 years of age and in immunosuppressed patients.^\[[@R28]\]^ Our data indicate that although 80% of cases belonged to the age group \<10 years old, the peak incidence was met at the age group (≥2, \<5).

The available reference data on the frequency of respiratory co-infections vary, although most reported percentages are higher than our results. In a study of 315 respiratory samples from children under 6 years of age, the FA-RP identified multiple co-infections (39%) with 2, 3, 4, and up to 5 different viruses.^\[[@R29]\]^ Co-infection has also been found in 31%,^\[[@R13]\]^ 36%,^\[[@R9]\]^ 37%,^\[[@R10]\]^ 42%,^\[[@R30]\]^ and 51.8%^\[[@R31]\]^ of positive respiratory samples. In our study, 9% of all our respiratory patients had multiple pathogens and 16% of all positive respiratory patients (almost 1 of 6 positive samples appeared with co-detections). There is no obvious explanation about the significance of lower frequency of co-detection in our series of patients. However, the predominance of HRV in our single and multiple detections is in accordance with previously published data.^\[[@R32]\]^ Moreover, HRV/Adv and HRV/RSV combinations have been previously mentioned as the most frequent co-infection patterns.^\[[@R30],[@R33]\]^ Interestingly, it has been suggested that the presence of RSV reduces the probability of rhinovirus infection, but that, if a co-infection occurs, both viruses cause clinical symptoms.^\[[@R34]\]^ Regarding the age-related distribution of multiple pathogens, our observation that patients under 5 years of age were more likely to have multiple detections, is almost in accordance with the eliminated previously published data.^\[[@R33],[@R35]--[@R37]\]^ Nevertheless, Tramuto et al have also noticed that most of their patients with multiple etiology were adults and elderly.^\[[@R24]\]^

In conclusion, understanding the viral etiology and age-specific incidence of URIs can help identify risk groups and probably inform vaccine delivery. In this study, HRV predominated in almost all ages, Adv in the age group (≥2, \<5) and Influenza was second in the ages (≥18). Finally, it was remarkable that the negative samples were mostly attributed to older ages, with a peak incidence in the age group (≥45, \<65), confirming that, as the age of the patient increases, the positivity rate for the PCR decreases proportionately,^\[[@R32]\]^ a finding that needs further explanation.
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